Evidence map›Paper›PMID 35582503›Full record

ArticleNorthern clinics of Istanbul2022

Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection.

Sadrettin Pence, Burcu Caykara, Halime Hanim Pence, Saban Tekin, Birsen Cevher Keskin, Ali Tevfik Uncu, Ayse Ozgur Uncu, Erman Ozturk

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Northern clinics of Istanbul, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sadrettin PenceDepartment of Physiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-9453-4166
Burcu CaykaraDepartment of Physiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-7063-2140
Halime Hanim PenceDepartment of Biochemistry, Health Sciences University Faculty of Medicine, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-8346-1018
Saban TekinDepartment of Medical Biology, Health Sciences University, Faculty of Medicine, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-2641-6293
Birsen Cevher KeskinTUBITAK, Marmara Research Center, Gene Engineering and Biotechnology Institute, Kocaeli, Turkey.ORCID https://orcid.org/0000-0003-3977-5797
Ali Tevfik UncuDepartment of Molecular Biology and Genetics, Necmettin Erbakan University Faculty of Science, Konya, Turkey.ORCID https://orcid.org/0000-0003-4729-5750
Ayse Ozgur UncuDepartment of Biotechnology, Necmettin Erbakan University Faculty of Science, Konya, Turkey.ORCID https://orcid.org/0000-0001-6435-579X
Erman OzturkDivision of Hematology, Department of Internal Diseases, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-1559-8047
Istanbul Medeniyet University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Coronavirus disease 2019 (COVID-19), leading to mild infection (MI), acute respiratory distress syndrome or death in different persons. Although the basis of these variabilities has not been fully elucidated, some possible findings have been encountered. In the present study, we aimed to reveal genes with different expression profiles by next-generation sequencing of RNA isolated from blood taken from infected patients to reveal molecular causes of different response. Methods: Two healthy, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative control individuals (NCI), two SARS-CoV-2-positive patients who have MI, and two patients who have critical infection (CI) were included in the study. Total RNA was extracted from blood samples and sequenced. Raw RNA-Seq data were analyzed on Galaxy platform for the identification of differentially expressed genes and their pathway involvements. Results: We found that 199 and 521 genes were downregulated in whole blood of COVID-19-positive CI patients compared to NCI and MI patients, respectively. We identified 21 gene ontology pathways commonly downregulated in CI patients compared to both NCI and MI, mostly associated with innate and adaptive immune responses. Three hundred and fifty-four and 600 genes were found to be upregulated compared to NCI and MI, respectively. Upregulated six pathways included genes that function in inflammatory response and inflammatory cytokine release. Conclusion: The transcriptional profile of CI patients deviates more significantly from that of MI in terms of the number of differentially expressed genes, implying that genotypic differences may account for the severity of SARS-CoV-2 infection and inflammatory responses through differential regulation of gene expression. Therefore, further studies that involve whole genome analysis coupled with differential expression analysis are required in order to determine the dynamics of genotype - gene expression profile associations.

Indexed as

COVID-19gene ontologyimmunityinnateplatelet activationRNA-Seq

Identifiers

PMID35582503
PMCPMC9039630
OpenAlexW4213009655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.